Product Name: Anti-ANDV Glycoprotein Recombinant Antibody (SAA3004)
Biological Function:
The Anti-ANDV Glycoprotein Recombinant Antibody (SAA3004) is a highly specific and potent antibody that targets the glycoprotein of the Andes virus (ANDV). This recombinant antibody is designed to bind to the glycoprotein of ANDV, inhibiting its ability to infect host cells. This makes it an essential tool for researchers studying the pathogenesis of ANDV and developing potential treatments for ANDV infections.
Main Applications:
The Anti-ANDV Glycoprotein Recombinant Antibody (SAA3004) has a wide range of applications in the field of biotechnology. Its main application is in research and development, where it can be used to study the structure and function of the ANDV glycoprotein. It can also be used in diagnostic assays to detect the presence of ANDV in patient samples. Additionally, this antibody can be used in the development and testing of potential vaccines and therapeutics for ANDV infections.
Experimental Use Cases:
The Anti-ANDV Glycoprotein Recombinant Antibody (SAA3004) has been extensively tested in various experimental settings, and its effectiveness has been demonstrated in several studies. In one study, the antibody was used to successfully neutralize ANDV in vitro, inhibiting its ability to infect host cells. In another study, it was shown to provide protection against ANDV infection in animal models. These findings highlight the potential of this antibody as a valuable tool in the fight against ANDV infections.
This highly specific and potent Anti-ANDV Glycoprotein Recombinant Antibody (SAA3004) is designed to target the glycoprotein of the Andes virus (ANDV). Its main applications include research and development, diagnostic assays, and the development of potential vaccines and therapeutics for ANDV infections. Through extensive experimental use cases, its effectiveness in neutralizing ANDV and providing protection against infection has been demonstrated.
Conclusion:
In conclusion, the Anti-ANDV Glycoprotein Recombinant Antibody (SAA3004) is a highly specific and potent antibody that targets the glycoprotein of the Andes virus. Its main applications in research and development, diagnostic assays, and potential treatments for ANDV infections make it an essential tool for biotech researchers. With its proven effectiveness in neutralizing ANDV and providing protection against infection, this antibody has the potential to make a significant impact in the fight against ANDV.
There are no reviews yet.